ICD-10 Code E16.1: Other hypoglycemia diagnosis guide

Key Takeaways

ICD-10 Code E16.1 is a billable ICD-10-CM code for other hypoglycemia – non-diabetic, non-neonatal low blood sugar including alimentary, autoimmune, and reactive subtypes.

E16.1 carries Excludes1 notes blocking simultaneous use with diabetes hypoglycemia codes (E08.649, E10.649, E11.649, E13.649), neonatal hypoglycemia (P70.4), and hypoglycemia in infant of diabetic mother (P70.1).

From FY2025 onward, coders should add E16.A1, E16.A2, or E16.A3 to specify hypoglycemia severity level when documented by the provider.

Pabau’s claims management software and structured patient records support accurate E16.1 documentation and clean claim submission for endocrinology and primary care practices.

ICD-10 Code E16.1 is classified as “Other hypoglycemia” within the ICD-10-CM Tabular List. It sits under category E16 (Other disorders of pancreatic internal secretion), within the E15-E16 block (Other disorders of glucose regulation and pancreatic internal secretion), Chapter 4 (Endocrine, nutritional and metabolic diseases, E00-E89).

The code applies to hypoglycemia that is neither drug-induced (E16.0), unspecified (E16.2), nor attributable to diabetes or neonatal causes. It represents a distinct group of non-diabetic hypoglycemic conditions with endogenous or functional etiologies, maintained by the National Center for Health Statistics under CMS ICD-10-CM annual updates.

Inclusion terms under E16.1

The ICD-10-CM Tabular List specifies the following inclusion terms, all of which map to ICD-10 Code E16.1 and should be coded here when documented by the treating provider:

• Alimentary hyperinsulinemia – excess insulin secretion triggered by rapid nutrient absorption after meals
• Alimentary hypoglycemia – post-meal blood glucose drop, often following gastric surgery
• Autoimmune hypoglycemia – insulin receptor antibody-mediated low blood sugar without exogenous insulin
• Functional hyperinsulinism – elevated insulin secretion without structural pancreatic pathology
• Functional non-hyperinsulinemic hypoglycemia – glucose drop in the absence of elevated insulin levels
• Hyperinsulinism NOS – hyperinsulinism not otherwise specified
• Reactive hypoglycemia – postprandial glucose nadir occurring 2-4 hours after eating

Practices managing endocrinology or metabolic health EMR workflows will encounter most of these subtypes in outpatient and follow-up documentation. The inclusion list is exhaustive as written in the official tabular – coders should not apply E16.1 to conditions not listed here unless they lack a more specific code.

ICD-10 Code E16.1 Excludes1 and Excludes2 notes

The Excludes1 designation is a hard coding rule: the excluded codes cannot be used at the same time as E16.1 under any circumstance. When a patient’s hypoglycemia is attributable to diabetes or to neonatal causes, the diabetes or neonatal code replaces E16.1 entirely.

These exclusions are verified in the AAPC Codify ICD-10-CM lookup and reflect the current FY2026 tabular rules. A diabetic patient experiencing hypoglycemia requires the appropriate E08-E13 diabetes code with the 5th and 6th character extensions, not E16.1. Submitting E16.1 for a known diabetic will trigger automated payer edits and potential claim denial.

Use additional code: E16.A- hypoglycemia level codes

For encounters coded with ICD-10 Code E16.1, the ICD-10-CM tabular instruction states: “Use additional code for hypoglycemia level, if applicable (E16.A-).” This instruction applies when the provider documents the severity level of the hypoglycemic episode.

The E16.A- subcategory was introduced in recent ICD-10-CM updates and covers three levels of severity:

• E16.A1 – Hypoglycemia level 1: blood glucose 54-70 mg/dL, requiring fast-acting carbohydrate intervention but not emergency assistance
• E16.A2 – Hypoglycemia level 2: blood glucose below 54 mg/dL, clinically significant, often requiring third-party assistance
• E16.A3 – Hypoglycemia level 3: severe cognitive impairment requiring emergency intervention regardless of glucose reading

When the provider documents the hypoglycemia level in the encounter notes, coders should append the appropriate E16.A- code as a secondary code. The instruction is “if applicable” – meaning it is conditional on documentation, not mandatory for every E16.1 claim. Practices using claims management software with structured diagnosis code fields can flag these secondary codes at the point of claim submission to reduce manual oversight errors.

E16.0, ICD-10 Code E16.1, and E16.2: Choosing the right code

The E16 subcategory offers three distinct hypoglycemia codes for non-diabetic, non-coma presentations. Selecting the wrong one generates medical necessity mismatches and can prompt payer requests for clinical records.

The critical distinction between E16.0 and E16.1 is etiology: if a drug caused the episode, E16.0 applies with an adverse-effect code. If the episode is endogenous, functional, or immune-mediated without drug causation, E16.1 is correct. E16.2 is a last-resort code – the ICD List reference tool and the official guidelines both direct coders to use the most specific code available.

Functional medicine and integrative practices that assess reactive hypoglycemia as part of metabolic panels will often document sufficient clinical detail to support E16.1 over E16.2. Providers using functional medicine practice software with structured SOAP note templates can include the etiology language needed to justify E16.1 specificity at audit.

Streamline your ICD-10 coding workflows

Pabau's structured patient records and claims management tools help endocrinology, functional medicine, and primary care practices document and submit E16.1 claims accurately. Reduce denials and keep coding current with FY2026 updates.

Book a demo

Documentation requirements for ICD-10 Code E16.1

Claim denials for E16.1 often follow from incomplete documentation rather than wrong code selection. Payers auditing hypoglycemia claims look for specific clinical evidence that the episode falls within the E16.1 inclusion set. These are the documentation elements that support medical necessity:

• Confirmed non-diabetic status: the encounter record should note absence of a diabetes diagnosis, or clearly document that the hypoglycemia is unrelated to any existing diabetic condition
• Blood glucose measurement: a recorded glucose value (fingerstick or lab) at the time of the episode strengthens the claim and supports adding E16.A- severity codes
• Etiology language: use the exact ICD-10-CM inclusion terms in your documentation wherever possible – “reactive hypoglycemia,” “alimentary hypoglycemia,” “autoimmune hypoglycemia” map directly to E16.1 inclusion terms
• Timing details for reactive/alimentary types: note the postprandial timeframe (e.g., “symptoms occurred 2-3 hours after eating”) to establish reactive or alimentary etiology
• Exclusion of drug causation: if the patient takes any medication associated with hypoglycemia, the record should explicitly state whether drug causation was ruled out, distinguishing the episode from E16.0

Practices that use digital intake forms capturing medication history and recent dietary patterns create a natural documentation trail supporting the etiology distinctions above. HIPAA-compliant storage of this intake data matters just as much as the clinical note itself, as payers can request the full encounter record at audit. Maintaining HIPAA-compliant documentation practices for metabolic encounters reduces audit exposure significantly.

CPT codes commonly paired with E16.1

E16.1 most frequently appears as the primary diagnosis code on outpatient endocrinology, primary care, or urgent care claims. The CPT codes below are the most common pairings for non-diabetic hypoglycemia encounters:

• 99213 / 99214: established patient office or outpatient visit (most common for follow-up hypoglycemia management)
• 99202 / 99203: new patient office visit (initial presentation with hypoglycemia symptoms)
• 99285: high-complexity emergency department visit (Level 5 ED encounter, used for severe hypoglycemic episodes requiring emergency care)
• 82947: glucose quantitative (fingerstick or serum glucose test at the point of care)
• 83036: hemoglobin A1c (when ordered to confirm non-diabetic status as part of hypoglycemia workup)

Pairing E16.1 with glucose testing CPT codes strengthens medical necessity for the diagnosis. Payers in some plans require an objective glucose measurement to accept reactive or functional hypoglycemia claims. Practices serving weight management patients should note that weight loss clinic software that integrates lab ordering with the patient record can pre-populate the glucose values needed to support these code pairings.

Related codes in the E15-E16 block and adjacent categories

Understanding the codes adjacent to E16.1 helps coders make accurate selections and avoid crossover errors. The E15-E16 block and nearby categories provide context for what E16.1 does and does not cover.

Practices that also code for ICD-10-CM coding for neurological diagnoses or situational anxiety ICD-10 coding guidance should note that E16.1 can appear as a comorbid secondary code alongside psychiatric and neurological primaries, where hypoglycemia contributes to a patient’s broader symptom picture. The WHO ICD-10 browser provides the international classification hierarchy for understanding how the E16 block sits within Chapter 4’s endocrine structure.

Billing and reimbursement notes for ICD-10 Code E16.1

E16.1 is confirmed billable and valid for claim submission across Medicare, Medicaid, and commercial insurance in FY2026. Payer-specific reimbursement policies vary, so absolute payment guarantees cannot be made, but the code itself is not subject to any Medicare NCCI edit that blocks it from standard outpatient E&M claims.

Several billing patterns are worth noting for practices submitting E16.1 regularly:

• Place of service matters: E16.1 on a hospital outpatient claim (POS 22) will be reimbursed under the OPPS fee schedule, while POS 11 (office) claims follow the Medicare Physician Fee Schedule rate for the paired E&M code
• Secondary diagnosis sequencing: when E16.1 accompanies a primary diagnosis (e.g., a post-bariatric surgery follow-up), list the surgical sequela as principal and E16.1 as secondary, unless the hypoglycemia was the main reason for the encounter
• Carrier judgment on E16.A- codes: some payers have not yet updated their adjudication rules to recognize E16.A1-E16.A3 as valid secondary codes for E16.1 claims. If a claim returns with an edit on E16.A-, check the payer’s current ICD-10-CM edit file before resubmitting
• ICD-10-CM Alphabetic Index entry: the index entry for “Hypoglycemia” branches to E16.1 under the subterms “alimentary,” “autoimmune,” “functional,” “hyperinsulinism NOS,” and “reactive” – verify the index path when coding from provider narrative

Practices managing high-volume metabolic and endocrinology billing benefit from structured patient records that link diagnosis codes to encounter notes, making it straightforward to pull supporting documentation when a payer requests clinical records for an E16.1 claim. Keeping other ICD-10-CM diagnostic code references organized within the same practice management system reduces lookup time during claim preparation.

Conclusion

Non-diabetic hypoglycemia coding depends on precise etiology documentation. When the encounter record establishes alimentary, autoimmune, reactive, or functional hyperinsulinism without drug causation and without diabetes, ICD-10 Code E16.1 is the correct and most specific billable code available.

Pabau’s claims management software supports endocrinology, metabolic health, and primary care practices in building the documentation workflows that make E16.1 coding accurate and defensible. To see how Pabau structures diagnosis code capture and claim submission, book a demo and review the clinical documentation features with your team.

Continue your research

Want to reduce ICD-10 coding errors across your team? Digital forms let you build structured intake templates that capture the etiology language needed to support E16.1 and E16.A- secondary codes at audit.

Frequently Asked Questions